Clario selects TransPerfect technology to reduce translation turnaround time by 30%

NEW YORK AND PHILADELPHIA-(BUSINESS WIRE)–TransPerfect, the world’s largest provider of language and technology solutions for global businesses, today announced that its GlobalLink Applanga technology has been selected by Clario to streamline translation processes.

Clario is a healthcare technology company that delivers the leading endpoint technology solutions for decentralized (DCT), hybrid and site-based clinical trials. Clario’s Translation Workbench is used to streamline the localization process, including managing multilingual content for licensed scales and data collection materials, as well as ensuring screen accuracy. Managing around 150 surveys at a time, with each survey involving an average of 20 languages ​​and eight assessments, Clario needed technology that offered them the automation to speed up the eCOA survey launch process.

GlobalLink Applanga is a cloud-based translation management system with features designed specifically for web-based applications, including portable devices and clinical applications, enabling Clario to more effectively address application localization requirements.

By connecting to Applanga via API, Clario Translation Workbench initiates the localization process and streamlines the review and approval of screenshots. Screenshot capture is automated for every rating, text download and screenshot push with minimal effort.

As a result of implementing Applanga, Clario experienced a 30% reduction in runtime. These reductions were achieved by reducing the time spent communicating between TransPerfect and Clario, eliminating the manual work required to generate accurate screenshots and translations of eCOA applications, and minimizing defects and human error, which reduced the burden on assurance staff of quality.

“Our customers need to deploy studies in multiple countries and provide patients with access to accurate and timely translations of their electronic clinical outcome assessments. Without them, pharmaceutical and biopharmaceutical customers face delays in getting new drugs to patients, and patients could be unable to provide vital information about their health. With Clario’s global reach and TransPerfect’s technology, we can help increase patient access and accelerate overall study setup time,” said Terry Burke, EVP eCOA.

TransPerfect President and CEO Phil Shaw noted, “Clario integrated Applanga in a way that allowed them to improve quality and efficiency. We are pleased that our technology has helped them reduce risk, reduce costs and succeed in their mission to bring treatments to market safely and quickly.

About Clario

Clario is a leading technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and healthcare partners. Across decentralized and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry enable our partners to transform lives. Clario’s Trial Anywhere™ solutions have powered hybrid and decentralized clinical trials (DCT) for more than 20 years, enabling sponsors to collect high-quality endpoint data from any modality or location while improving patient experience and diversity. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion and respiratory endpoints. With 30 facilities in nine countries, Clario’s global team of scientific, technological and operational experts has helped deliver more than 19,000 trials and 870 regulatory approvals for more than 5 million patients in 120 countries. Our innovation has transformed clinical trials for 50 years.

About TransPerfect

TransPerfect is the world’s largest provider of language and technology solutions for global businesses. From offices in over 100 cities on six continents, TransPerfect offers a full range of services in more than 200 languages ​​to clients worldwide. More than 6,000 global organizations use TransPerfect’s GlobalLink® technology to simplify multilingual content management. With an unmatched commitment to quality and customer service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.

Leave a Comment